Serum Institute To Pause Vaccine Trials In India After Drug Controller's Notice | Read

PUBLISHED ON: September 10, 2020 | Duration: 1 min, 57 sec

  
loading..
Serum Institute of India, which is manufacturing the coronavirus vaccine Covishield being developed by the Oxford University along with pharma major AstraZenca, today said it will stop the Phrase 3 trials that were to begin in India next week. The vaccine trial was stopped across four nations as a precautionary measure after one of the recipients in the UK showed some potentially adverse symptoms.
ALSO WATCH
FYI: Everything You Need To Know About Vaccines

................................ Advertisement ................................

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com